Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuersunayi Abudureheman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Talanta|May 29, 2023
A novel His-tag-binding aptamer for recombinant protein detection and T cell-based immunotherapyLi-Ting Yang, Tuersunayi Abudureheman, Wei-Wei Zheng, et al.
Bioconjugate Chemistry|April 25, 2024
Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation SystemTuersunayi Abudureheman, Hang Zhou, Li-Ting Yang, et al.
Protein Science : a Publication of the Protein Society|March 19, 2024
Construction of a versatile fusion protein for targeted therapy and immunotherapyXiu-Song Huang, Li-Ting Yang, Ke Yang, et al.
Analytical Chemistry|September 13, 2024
Efficient Capture and Traceless Release of Functional CD8<sup>+</sup> T Cells with a Microfluidic Chip for Enhanced <i>In Vitro</i> and <i>In Viv</i><i>o</i> CD4-CAR TransductionAynur Abdulla, Tuersunayi Abudureheman, Kaiming Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 26, 2023
CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune EscapeHang Zhou, Tuersunayi Abudureheman, Wei-Wei Zheng, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2023
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatmentWei-Wei Zheng, Hang Zhou, Ping Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 9, 2020
Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated GlycolysisMeng-Yi Zhang, Sheng-Li Liu, Wen-Li Huang, et al.
Frontiers in Oncology|April 23, 2021
CDK7 Inhibitor THZ1 Induces the Cell Apoptosis of B-Cell Acute Lymphocytic Leukemia by Perturbing Cellular MetabolismTuersunayi Abudureheman, Jing Xia, Ming-Hao Li, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic MetabolismWen-Li Huang, Tuersunayi Abudureheman, Jing Xia, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Talanta|May 29, 2023
A novel His-tag-binding aptamer for recombinant protein detection and T cell-based immunotherapyLi-Ting Yang, Tuersunayi Abudureheman, Wei-Wei Zheng, et al.
Bioconjugate Chemistry|April 25, 2024
Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation SystemTuersunayi Abudureheman, Hang Zhou, Li-Ting Yang, et al.
Protein Science : a Publication of the Protein Society|March 19, 2024
Construction of a versatile fusion protein for targeted therapy and immunotherapyXiu-Song Huang, Li-Ting Yang, Ke Yang, et al.
Analytical Chemistry|September 13, 2024
Efficient Capture and Traceless Release of Functional CD8<sup>+</sup> T Cells with a Microfluidic Chip for Enhanced <i>In Vitro</i> and <i>In Viv</i><i>o</i> CD4-CAR TransductionAynur Abdulla, Tuersunayi Abudureheman, Kaiming Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 26, 2023
CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune EscapeHang Zhou, Tuersunayi Abudureheman, Wei-Wei Zheng, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2023
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatmentWei-Wei Zheng, Hang Zhou, Ping Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 9, 2020
Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated GlycolysisMeng-Yi Zhang, Sheng-Li Liu, Wen-Li Huang, et al.
Frontiers in Oncology|April 23, 2021
CDK7 Inhibitor THZ1 Induces the Cell Apoptosis of B-Cell Acute Lymphocytic Leukemia by Perturbing Cellular MetabolismTuersunayi Abudureheman, Jing Xia, Ming-Hao Li, et al.
Frontiers in Cell and Developmental Biology|March 22, 2021
CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic MetabolismWen-Li Huang, Tuersunayi Abudureheman, Jing Xia, et al.
Pageof 1